Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future Perspectives
出版年份 2021 全文链接
标题
Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future Perspectives
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-09-04
DOI
10.3389/fimmu.2021.713358
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Maturation and Phenotypic Heterogeneity of Human CD4+ Regulatory T Cells From Birth to Adulthood and After Allogeneic Stem Cell Transplantation
- (2021) Tiago R. Matos et al. Frontiers in Immunology
- Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide
- (2021) Benedetta Rambaldi et al. Blood Advances
- Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
- (2021) Reid W. Merryman et al. LEUKEMIA
- Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab
- (2021) Shuntaro Ikegawa et al. LEUKEMIA
- Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing
- (2021) Yael C. Cohen et al. NATURE MEDICINE
- Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia
- (2021) Antonio Pierini et al. Blood Advances
- RNA-seq of human T cells after hematopoietic stem cell transplantation identifies Linc00402 as a regulator of T cell alloimmunity
- (2021) Daniel Peltier et al. Science Translational Medicine
- Donor Treg expansion by liposomal α‐galactosylceramide modulates Tfh cells and prevents sclerodermatous chronic graft‐versus‐host disease
- (2021) Hiroyuki Sugiura et al. Immunity Inflammation and Disease
- Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression
- (2021) Makoto Nakamura et al. Scientific Reports
- Sustained Immunogenic and Clinical Effects of Low-Dose Interleukin-2 Therapy with an Intermittent Maintenance Method for Refractory Chronic Graft-Versus-Host Disease: Results of Phase1/2a LDIL2-01 Study
- (2020) Yusuke Meguri et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors
- (2020) Betül Oran et al. CANCER
- Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy
- (2020) Juan C. Nieto et al. LEUKEMIA
- Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD
- (2020) Bruce R. Blazar et al. Nature Reviews Clinical Oncology
- Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
- (2020) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study
- (2020) Suman Paul et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses
- (2020) Joel Kidman et al. Frontiers in Immunology
- Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT
- (2020) Mahinbanu Mammadli et al. Frontiers in Immunology
- Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report
- (2019) Lucy B. Cook et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune Reconstitution after T-cell Replete HLA-Haploidentical Transplantation
- (2019) Shannon R. McCurdy et al. SEMINARS IN HEMATOLOGY
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression
- (2019) Lucas P. Wachsmuth et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasma exchange eliminates residual mogamulizumab but does not warrant prompt recovery of peripheral Treg levels
- (2019) Hiroyuki Sugiura et al. TRANSFUSION AND APHERESIS SCIENCE
- A prospective observational study of immune reconstitution following transplantation with post‐transplant reduced‐dose cyclophosphamide from HLA ‐haploidentical donors
- (2019) Hirohisa Nakamae et al. TRANSPLANT INTERNATIONAL
- Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation
- (2019) Xiuhua Su et al. Cellular & Molecular Immunology
- The role of regulatory T cells in graft-versus-host disease management
- (2019) Jennifer S. Whangbo et al. Expert Review of Hematology
- Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil
- (2018) Charles Herbaux et al. BLOOD
- Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
- (2018) Philippe Armand et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors Before and After Allogeneic transplantation
- (2018) Awais Ijaz et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Anti-CTLA-4 immunotherapy does not deplete FOXP3+ regulatory T cells (Tregs) in human cancers-Letter
- (2018) Roberto Ferrara et al. CLINICAL CANCER RESEARCH
- A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease
- (2018) Laurence B. Peterson et al. JOURNAL OF AUTOIMMUNITY
- Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives
- (2017) Ken-ichi Matsuoka INTERNATIONAL JOURNAL OF HEMATOLOGY
- Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
- (2017) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets
- (2017) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
- (2016) John Koreth et al. BLOOD
- A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation
- (2016) S. Nikiforow et al. HAEMATOLOGICA
- Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality
- (2016) Shigeo Fuji et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
- (2016) Anas Younes et al. LANCET ONCOLOGY
- Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model
- (2016) Baihao Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation
- (2016) S. Nikiforow et al. HAEMATOLOGICA
- Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
- (2015) C. G. Brunstein et al. BLOOD
- Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD
- (2015) A. C. Alho et al. BLOOD
- Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease
- (2015) Anke Theil et al. CYTOTHERAPY
- Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response
- (2015) You Jeong Lee et al. IMMUNITY
- PD-1 Upregulated on Regulatory T Cells during Chronic Virus Infection Enhances the Suppression of CD8+T Cell Immune Response via the Interaction with PD-L1 Expressed on CD8+T Cells
- (2015) Hyo Jin Park et al. JOURNAL OF IMMUNOLOGY
- Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice
- (2014) S. Ganguly et al. BLOOD
- CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells
- (2014) D. Schneidawind et al. BLOOD
- Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
- (2014) C. G. Kanakry et al. BLOOD
- HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
- (2014) M. F. Martelli et al. BLOOD
- Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
- (2014) S. Spoerl et al. BLOOD
- Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation
- (2014) K. Murase et al. HAEMATOLOGICA
- Lineage stability and phenotypic plasticity of Foxp3+regulatory T cells
- (2014) Shohei Hori IMMUNOLOGICAL REVIEWS
- Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
- (2014) Jason A. Dubovsky et al. JOURNAL OF CLINICAL INVESTIGATION
- Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
- (2014) Christopher G. Kanakry et al. JOURNAL OF CLINICAL ONCOLOGY
- Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells
- (2014) Julio Gomez-Rodriguez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality
- (2013) A. Saha et al. BLOOD
- Thymic Damage, Impaired Negative Selection, and Development of Chronic Graft-versus-Host Disease Caused by Donor CD4+ and CD8+ T Cells
- (2013) T. Wu et al. JOURNAL OF IMMUNOLOGY
- Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells
- (2013) Wim Pierson et al. NATURE IMMUNOLOGY
- A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
- (2013) Taku Okazaki et al. NATURE IMMUNOLOGY
- Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
- (2013) C. G. Kanakry et al. Science Translational Medicine
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
- (2013) K.-i. Matsuoka et al. Science Translational Medicine
- STAT3 Transcription Factor Promotes Instability of nTreg Cells and Limits Generation of iTreg Cells during Acute Murine Graft-versus-Host Disease
- (2012) Arian Laurence et al. IMMUNITY
- Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
- (2012) Takashi Ishida et al. JOURNAL OF CLINICAL ONCOLOGY
- Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
- (2012) Leo Luznik et al. SEMINARS IN ONCOLOGY
- Prophylactic Effects of Interleukin-2 Receptor Antagonists against Graft-versus-Host Disease Following Unrelated Donor Peripheral Blood Stem Cell Transplantation
- (2011) Jun Fang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Thymic T-cell development in allogeneic stem cell transplantation
- (2011) W. Krenger et al. BLOOD
- Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation
- (2011) Y. Kawano et al. BLOOD
- Instability of Foxp3 Expression Limits the Ability of Induced Regulatory T Cells to Mitigate Graft versus Host Disease
- (2011) A. Beres et al. CLINICAL CANCER RESEARCH
- High TCR diversity ensures optimal function andhomeostasis of Foxp3+regulatory Tcells
- (2011) Lisa Föhse et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Response to self antigen imprints regulatory memory in tissues
- (2011) Michael D. Rosenblum et al. NATURE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Upfront Denileukin Diftitox as in vivo regulatory T-cell depletion in order to enhance vaccination effects in a canine allogeneic hematopoietic stem cell transplantation model
- (2011) Anne Knueppel et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Pharmacologic Expansion of Donor-Derived, Naturally Occurring CD4+Foxp3+ Regulatory T Cells Reduces Acute Graft-versus-Host Disease Lethality Without Abrogating the Graft-versus-Leukemia Effect in Murine Models
- (2010) Omar Duramad et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
- (2010) L. Luznik et al. BLOOD
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
- (2010) C. G. Brunstein et al. BLOOD
- Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
- (2010) Thomas R. Malek et al. IMMUNITY
- Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation
- (2010) Ken-ichi Matsuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma
- (2010) Kazuhito Yamamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Raising the NKT cell family
- (2010) Dale I Godfrey et al. NATURE IMMUNOLOGY
- Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation
- (2009) Emmanuel Zorn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Fatal Hyperacute Graft-versus-Host Disease following Denileukin Diftitox Treatment for Recurrent T Cell Lymphoma after Allogeneic Stem Cell Transplantation
- (2009) Sapna Khubchandani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease
- (2009) A. B. Pillai et al. BLOOD
- First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells
- (2009) Piotr Trzonkowski et al. CLINICAL IMMUNOLOGY
- CD4 + CD25 + Foxp3 + T Regulatory Cells with Limited TCR Diversity in Control of Autoimmunity
- (2009) Dennis Adeegbe et al. JOURNAL OF IMMUNOLOGY
- Graft-versus-host disease
- (2009) James LM Ferrara et al. LANCET
- Regulatory T cells exert checks and balances on self tolerance and autoimmunity
- (2009) Kajsa Wing et al. NATURE IMMUNOLOGY
- Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT
- (2008) A. L. Bayer et al. BLOOD
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- Alpha-galactosylceramide-driven immunotherapy for allergy
- (2008) Yasuyuki Ishii Frontiers in Bioscience-Landmark
- Homeostasis of Naive and Memory T Cells
- (2008) Charles D. Surh et al. IMMUNITY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started